國務院(yuan)聯防聯控機制(zhi)(zhi)印(yin)發(fa)關于在新型冠狀病(bing)毒(du)感(gan)染(ran)醫(yi)(yi)療救治中(zhong)(zhong)(zhong)(zhong)進一步(bu)發(fa)揮中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥特(te)色優勢的(de)通知，其中(zhong)(zhong)(zhong)(zhong)提出，重(zhong)癥(zheng)醫(yi)(yi)療救治中(zhong)(zhong)(zhong)(zhong)要堅持(chi)“中(zhong)(zhong)(zhong)(zhong)西醫(yi)(yi)結(jie)合(he)、中(zhong)(zhong)(zhong)(zhong)西藥并用”原(yuan)則，進一步(bu)建(jian)立完善(shan)“有團隊(dui)、有機制(zhi)(zhi)、有措施(shi)、有成效”中(zhong)(zhong)(zhong)(zhong)西醫(yi)(yi)結(jie)合(he)醫(yi)(yi)療模(mo)式。二(er)級(ji)以上(shang)綜合(he)醫(yi)(yi)院(yuan)、專(zhuan)科醫(yi)(yi)院(yuan)要建(jian)立新型冠狀病(bing)毒(du)感(gan)染(ran)醫(yi)(yi)療救治中(zhong)(zhong)(zhong)(zhong)西醫(yi)(yi)協作工(gong)作機制(zhi)(zhi)，院(yuan)級(ji)專(zhuan)家(jia)組(zu)應由中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)醫(yi)(yi)師和西醫(yi)(yi)醫(yi)(yi)師共同(tong)組(zu)建(jian)，中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)醫(yi)(yi)師應共同(tong)參(can)與患者(zhe)診療決策，開展聯合(he)查(cha)房、多學科會診、病(bing)例討論等(deng)。針(zhen)對重(zhong)癥(zheng)、危重(zhong)癥(zheng)患者(zhe)，要有經(jing)驗(yan)豐富的(de)中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)醫(yi)(yi)師參(can)加多學科聯合(he)會診，共同(tong)研究確定中(zhong)(zhong)(zhong)(zhong)西醫(yi)(yi)結(jie)合(he)治療措施(shi)，負責(ze)中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)治療和病(bing)情觀察。（國家(jia)中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥管理局網(wang)站）